“Advancing and shaping the future of the medicinal cannabis industry”

summerfield-336672_1920.jpg

Cannvalate is dedicated to improving the health and wellbeing of patients.

this is achieved by streamlining patient access, and bringing safe and effective cannabinoid-based products to the Australian market

 
1.png

DRUG DISCOVERY AND CANNABINOID RESEARCH

2.png

AUSTRALIA’S LARGEST NETWORK OF CANNABIS CLINICS

Medical Advisory Board Established.png

UNLOCKING THE AUSTRALIAN CANNABIS MARKETPLACE


Senior Management Team

 
Dr Sud Agarwal.png
Add heading 1.png
 
 
16.png
5 (2).png
 
15.png
Cannvalate Team (1).png
 
11.png
7 (2).png
 
14.png
8 (2).png
 
12.png
9 (2).png
 
13.png
3 (2).png
 
17.png
Cannvalate Team (2).png
 

Medical Advisory Board

 
10.png
11.png
12.png
13.png
14.png
15.png
16.png
17.png
Cannvalate Team.png

 

significant milestones achieved

 
Cannvalate Milestone.png

Medical Advisory Board established

Cannvalate Milestone.png

First medicinal cannabis company to be supported and financed by the medical community

Cannvalate Milestone.png

Patented medtech including an online marketplace platform and a pharmacovigilance app

 
Cannvalate Milestone.png

Four novel cannabinoid drugs licenced with orphan categories submitted

Cannvalate Milestone.png

Series A Round of fundraising oversubscribed in 7 days

Cannvalate Milestone.png

Secured investment from Australian Cannabis Fund

 
Cannvalate Milestone.png

Licenced to import and sell cannabis

Cannvalate Milestone.png

Cannvaclinics launched with 3 clinics registered in 24 hours

Cannvalate Milestone.png

Australian Cannabis Market Access (ACMA) launched with 4 international licenced producers registered

 

request investor pack

get in touch